Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.9266 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.81553 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.8982 | 65 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.8513 | 64 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.91543 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.97837 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.03112 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.87797 | 65 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.87433 | 65 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.88983 | 65 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.88888 | 65 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.89133 | 65 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.89725 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.89462 | 65 |